norethindrone and c-peptide

norethindrone has been researched along with c-peptide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V1
Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V1
Crook, D; Devenport, M; Godsland, IF; Wynn, V1
Bard, JM; Djøseland, O; Fruchart, JC; Gørbitz, C; Ose, L; Tonstad, S1
Cooper, AJ; Godsland, IF; Ross, D; Spencer, CP; Stevenson, JC; Whitehead, MI1
Arce, JC; Cyrowski, MS; Davidson, MH; Maki, AC; Maki, KC; Marx, P; Nanavati, N1
Godsland, IF; Manassiev, N; Proudler, AJ; Stevenson, JC; Whitehead, MI1

Trials

4 trial(s) available for norethindrone and c-peptide

ArticleYear
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women.
    Journal of internal medicine, 1995, Volume: 238, Issue:1

    Topics: Adult; Blood Glucose; C-Peptide; Cholesterol, LDL; Combined Modality Therapy; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Insulin; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Single-Blind Method; Treatment Outcome

1995
Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; C-Peptide; Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver; Middle Aged; Models, Theoretical; Norethindrone; Norethindrone Acetate; Pancreas; Postmenopause

2000
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
    Archives of internal medicine, 2000, Nov-27, Volume: 160, Issue:21

    Topics: Aged; Apolipoprotein A-I; Blood Coagulation Factors; Blood Glucose; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Glycated Hemoglobin; Humans; Insulin; Lipids; Lipoprotein(a); Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors; Treatment Outcome; Triglycerides

2000
Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism.
    Clinical endocrinology, 2013, Volume: 78, Issue:2

    Topics: Aged; Blood Glucose; C-Peptide; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Glucose; Humans; Insulin; Insulin Resistance; Middle Aged; Norethindrone; Norpregnenes

2013

Other Studies

3 other study(ies) available for norethindrone and c-peptide

ArticleYear
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:1

    Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes

1992
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    The New England journal of medicine, 1990, Nov-15, Volume: 323, Issue:20

    Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides

1990
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Contraception, 1995, Volume: 52, Issue:3

    Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors

1995